Within the Neuroscience Market , neuroimaging holds the largest share, reflecting its essential role in visualizing brain structure and function. According to the MRFR report, neuroimaging was valued at USD 8.0 billion in 2024 and is projected to grow to USD 12.0 billion by 2035. This segment encompasses technologies such as MRI, CT, and PET scanners, which are indispensable for diagnosing neurological disorders, guiding treatment, and conducting research. The dominance of neuroimaging is driven by its non-invasive nature, high spatial resolution, and the continuous development of advanced imaging techniques that provide deeper insights into brain connectivity and activity.

While neuroimaging leads, electrophysiology is the fastest-growing segment. Electrophysiology techniques, including EEG and EMG, record the electrical activity of the nervous system, providing real-time data on neuronal communication. These methods are essential for diagnosing epilepsy, sleep disorders, and neuromuscular conditions. The growth of this segment is fueled by technological advancements in electrode design, signal processing, and data analysis. The development of high-density EEG arrays and wireless, wearable devices is expanding the applications of electrophysiology in both clinical and research settings. The increasing use of EEG in brain-computer interfaces and neurofeedback therapies is also contributing to its rapid expansion.

Behavioral neuroscience, neurogenetics, and computational neuroscience represent other important technique segments. Behavioral neuroscience focuses on understanding the neural basis of behavior, while neurogenetics explores the genetic underpinnings of neurological disorders. Computational neuroscience uses mathematical models and simulations to understand brain function. The growth of these segments is driven by the increasing complexity of neuroscience research and the need for integrated, multi-disciplinary approaches. The convergence of these techniques is enabling researchers to build more comprehensive models of brain function and disease.

The segmentation by product shows that MRI systems hold the largest share, valued at USD 8.0 billion in 2024 and projected to grow to USD 12.0 billion by 2035. MRI's unparalleled ability to provide high-resolution images of soft tissue makes it the preferred choice for brain imaging. CT scanners are the fastest-growing product segment, driven by their speed and utility in emergency settings, particularly for stroke and trauma. The development of portable CT scanners is also expanding their use in point-of-care settings. The ongoing innovation in imaging technologies, including the integration of AI for image analysis, will continue to drive growth across these segments.